These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8799414)

  • 1. Adjuvant therapy following pancreatic resection for pancreatic duct carcinoma: a prospective randomized study.
    Lygidakis NJ; Stringaris K
    Hepatogastroenterology; 1996; 43(9):671-80. PubMed ID: 8799414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined immunopharmaceutical therapy of patients with unresectable pancreatic carcinoma.
    Lygidakis NJ; Ziras FA; Kyparidou E; Parissis J; Papadopoulou P; Venetsanou B
    Hepatogastroenterology; 1995; 42(6):1039-52. PubMed ID: 8847017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
    Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
    Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic head carcinoma: is pancreatic resection indicated for patients with stage III pancreatic duct cancer?
    Lygidakis NJ; Papadopoulou P
    Hepatogastroenterology; 1995; 42(5):587-96. PubMed ID: 8751219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
    Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consecutive re-explorations for final resection of initially unresectable pancreatic head carcinoma.
    Lygidakis NJ; Vlachos L; Raptis S; Sgourakis G; Mourikis D; Kehagias D
    Hepatogastroenterology; 1999; 46(28):2229-39. PubMed ID: 10521972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer.
    Pawlik TM; Abdalla EK; Barnett CC; Ahmad SA; Cleary KR; Vauthey JN; Lee JE; Evans DB; Pisters PW
    Arch Surg; 2005 Jun; 140(6):584-9; discussion 589-91. PubMed ID: 15967906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma.
    Shimada K; Sakamoto Y; Sano T; Kosuge T
    J Am Coll Surg; 2006 Sep; 203(3):345-52. PubMed ID: 16931307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended lymphadenectomy in cephalic pancreatoduodenectomy. Personal observations.
    Meriggi F; Gramigna P; Forni E
    Hepatogastroenterology; 2007 Mar; 54(74):549-55. PubMed ID: 17523320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
    Benassai G; Mastrorilli M; Mosella F; Mosella G
    J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
    Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
    Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cell mediated immunity in advanced pancreatic carcinoma before and after treatment with interleukin-2 (IL-2).
    Abdel-Wahab M; El-Shennawy F; Agha S; Ragab E; Fathi O; Sultan A; Elghawalby N; Ezzat F
    Hepatogastroenterology; 1999 May; 46 Suppl 1():1293-6. PubMed ID: 10429977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Patients with non-advanced pancreatic cancer benefit from extended lymphadenectomy].
    Popiela T; Kedra B; Sierzega M; Kubisz A
    Zentralbl Chir; 2002 Nov; 127(11):960-4. PubMed ID: 12476369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
    Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
    Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional targeting chemoimmunotherapy in patients undergoing pancreatic resection in an advanced stage of their disease: a prospective randomized study.
    Lygidakis NJ; Sgourakis G; Georgia D; Vlachos L; Raptis S
    Ann Surg; 2002 Dec; 236(6):806-13. PubMed ID: 12454519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical results of extended lymphadenectomy and intraoperative radiotherapy for pancreatic adenocarcinoma.
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Tanizawa Y
    Hepatogastroenterology; 2007 Mar; 54(74):564-9. PubMed ID: 17523323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma.
    Yoshida T; Matsumoto T; Sasaki A; Shibata K; Aramaki M; Kitano S
    Am J Surg; 2004 Jun; 187(6):736-40. PubMed ID: 15191867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductal adenocarcinoma of the pancreas head: survival after regional versus extended lymphadenectomy.
    Henne-Bruns D; Vogel I; Lüttges J; Klöppel G; Kremer B
    Hepatogastroenterology; 1998; 45(21):855-66. PubMed ID: 9684147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes.
    Martin RC; Scoggins CR; Egnatashvili V; Staley CA; McMasters KM; Kooby DA
    Arch Surg; 2009 Feb; 144(2):154-9. PubMed ID: 19221327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.